1King ED,O'Donnell CP,Smith PL,et al.A model of obstructive sleep apnea in normal humans:Role of the upper airway[J].Am J Respir Crit Care Med,2000,161:1979-1984.
3Kannel WB.Some lessons in cardiovascular epidemiology from Framingham[J].Am J Cardiol,1976,37:269-282.
4Lavie P,Ben-Yosef R,Rubin AE.Prevalence of sleep apnea syndrome among patients with essential hypertension[J].Am Heart J,1984,108:373-376.
5Carson JT,Heder JA,Ejnell H,et al.High prevalence of hypertension in sleep apnea patients independent of obesity[J].Am J Respir Crit Care Med,1994,150:72-77.
6Bonsignore MR,Marrone O,Insalaco G,et al.The cardiovascular effects of obstructive sleep apnoeas:Analysis of pathogenic mechanisms[J].Eur Respir J,1994,7:786-805.
7Kraiczi H,Hedner J,Peker Y,et al.Comparison of atenolol,amlodipine,enalapril,hydrochlorothiazide and losartan for antihypertensive treatment in patients with obstructive sleep apnea[J].Am J Respir Crit Care Med,2000,161:1423-1428.
8Grimpen F,Kanne P,Schule E,et al.Endothelin-plasma levels aren't elevated in patients with obstructive sleep apnea[J].Eur Respir J,2000,15:320-325.
10Hedner J,Carlson J,Ejnell H,et al.Sleep apnea,age and obesity:Independent risk factors for development of hypertension:High prevalence of hypertension independently of obesity[J].Am Rev respir Dis,1993,147:1018.
7Kraiczi,Hedner J,Peker Y.et al.Cimparson of atenolol,amlodipine,enalapril,hydrochlorothiazide and losartan for antihypertensive treatment in patients with obstructive sleep apnea[J].Am J Respir Crit Care Med,2000,161:1423-1428.
8Grimpen F,Kanne P,Schule E,et al.Endothelin-plasma level aren't eleveated in patients with obstructive sleepapnea[J].Eur Respir J,2000,15:320-325.
9Levisan PD,Mc Gravey ST,Carliad CC,et al.Adiposity and cardiovscualar risk factors in men with obstructive sleep apnea[J].Chest 1993,103:1336.
